LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 140 pages found matching zyprexa- Lilly Receives Zyprexa Greetings From Capitol Hill
Apr-27-07 Washington, DC: The Chairman and CEO of Eli Lilly, Sidney Taurel, has become a regular pen pal with lawmakers on Capitol Hill since the company's ten-year campaign to increase profits by promoting the off-label use of Zyprexa for patients covered by public health care programs became the focus of investigations in both houses of Congress. According... - J&J Concealed Dangers of Ortho Evra Birth Control Patch
Apr-16-07 Washington, DC: Tens of millions of prescriptions have been written for Johnson & Johnson's Ortho Evra birth control patch since it arrived on the market in 2002, and medical experts say the patch has harmed thousands of young women of childbearing age. In September 2006, the FDA warned that use of the patch, made by the Ortho-McNeil division of J&J,... - Patients Diagnosed Schizophrenic and Bipolar to boost Seroquel Sales
Apr-11-07 Washington, DC: For over a decade, drug makers have been influencing doctors to diagnose patients, especially those covered by public health care programs like Medicare and Medicaid, with mental illnesses to justify the over-prescribing of the new class of drugs known as "atypical" antipsychotics. For instance, Seroquel , marketed by AstraZeneca, is on... - April 2007 Big Pharma Litigation Update - Drugs (Part I)
Apr-5-07 Washington, DC: For the last two decades, illegal drug marketing schemes have paid off well for Big Pharma. However, as the old saying goes, all good things must come to an end, and every major drug company is currently involved in massive litigation. Some companies are facing thousands of lawsuits with a common complaint that the drug maker deliberatel... - Investigators Zero In on Pill Pushing Doctors
Mar-14-07 Washington, DC: The number one goal of drug makers in dispatching sales representatives to meet with doctors face-to-face is to increase sales by convincing doctors to prescribe drugs off-label for unapproved uses, by saying whatever it takes to achieve that goal. A May 2006, study titled, "Turning Medicine Into Snake Oil," analyzed FDA warning letters... - Makers of Zyprexa Risperdal and Seroquel Under Fire
Mar-9-07 Washington, DC: Eli Lilly, Johnson & Johnson, and AstraZeneca, are all named defendants in a new lawsuit filed by the state of Pennsylvania on February 26, 2007, to recover money paid through public health care programs to purchase Zyprexa , Risperdal, and Seroquel, and the costs of medical care for the people injured by these drugs. Pennsylvania... - Behind the Scenes Snake Oil Salesmen
Mar-7-07 Washington, DC: While the pharmaceutical industry's corrupt practice of peddling ineffective drugs and concealing dangerous side effects has come under scrutiny in recent years, critics say the contributions of the research scientists, academics, medical journals, and the FDA deserve far more credit for their part in the industry's overall marketing scheme... - Activists Take on Eli Lilly Over Off-Label Sale of Zyprexa
Feb-27-07 Washington, DC: On February 23, 2007, a new grass roots advocacy group issued a press release to rally support for attorney, Jim Gottstein, in his legal battle with Eli Lilly over his role in providing secret company documents obtained in litigation to the media to alert the public about the health risks associated with Zyprexa that were kept hidden si... - Another lawsuit filed against Eli Lilly's Zyprexa
Feb-25-07 Chicago, IL: Eli Lilly faces yet another court appearance to defend its anti-psychotic drug Zyprexa after a lawsuit was filed late last month in Illinois. The plaintiff filed the lawsuit claiming he now suffers from diabetes and permanent bodily and mental harm after taking Zyprexa. He also argues that his illness has caused mental anguish, emotiona... - More Zyprexa Postcards From the Edge
Feb-18-07 Washington, DC: On February 13, 2007, Judge Jack Weinstein issued a permanent injunction, prohibiting attorney, Jim Gottstein, and Dr David Egilman, an expert witness in litigation involving Zyprexa , from further disseminating certain Eli Lilly documents that were sealed with a court order until Mr Gottstein released them to the media in December 2006... - Zyprexa Injury Clock Keeps Ticking Away
Feb-2-07 San Jose, CA The on-going legal battle over the disclosure of secret Eli Lilly documents that reveal the serious health risks associated with Zyprexa and the company's off-label promotion of the drug involves a matter of grave public concern. But observers on the sidelines of this courtroom circus say the conduct of the judge in helping Lilly keep d... - Eli Lilly's Zyprexa Woes not Finished Yet
Feb-2-07 Washington, DC: Eli Lilly, makers of Zyprexa , may finally be feeling some of the sting of recent lawsuits. Late last month Eli Lilly announced that its fourth-quarter earnings had dropped, likely due to recent settlements of lawsuits related to Zyprexa. According to a report in the New York Times, Eli Lilly made $132 million in its fourth quarter; d... - Eli Lilly The Habitual Offender
Jan-25-07 Indianapolis, IN: The revelations that Eli Lilly concealed the side effects of Zyprexa and promoted the drug for unapproved uses is not newly discovered misconduct. It is a persistent pattern of conduct indicative of a nasty habit that needs breaking. After the secret company documents were leaked to the press last month by attorney, Jim Gottstein,... - Zyprexa Judge decides which Journalists have First Amendment Rights
Jan-16-07 Washington, DC The judge issuing injunctions in the Eli Lilly- Zyprexa -Documents case has decided that reporters at the New York Times enjoy the full protection of the First Amendment but that other reporters and media outlets do not. The secret documents at the center of this hailstorm were provided to the New York Times, and several other journalis... - Public has Right to know Secrets revealed in Zyprexa Documents
Jan-15-07 Washington, DC In deciding whether to allow Eli Lilly to continue to use court orders to hide documents that show the company illegally marketed Zyprexa for unapproved uses and failed to warn the public about the serious health risks associated with the drug for a decade, the court needs to consider the harm done to the public by Lilly's conduct. Th... - Lilly's Legal Battle over Zyprexa Documents Continues
Jan-8-07 On January 3, 2007, a hearing was held before Judge Jack Weinstein, in a US District Court in New York, on a motion by Eli Lilly to extend an injunction to conceal company documents that show Lilly hid the lethal side effects of Zyprexa for a decade and engaged in an illegal off-label marketing scheme to promote the drug for unapproved uses. Zyprexa... - Criminal Prosecution of Lilly Sought Over Zyprexa
Jan-4-07 California Attorney, Ted Chabasinski, is calling for the criminal prosecution of Eli Lilly executives for hiding the adverse effects of Zyprexa , based in part on articles last month in the New York Times which quote internal company documents that revealed that Lilly knew about the adverse effects for a decade but kept the information hidden. Mr Chab... - DSM Billing Bible - Big Pharma Best Seller
Dec-27-06 Washington, DC One-hundred percent of the experts involved in writing diagnostic criteria for mood disorders and schizophrenia for the, "Diagnostic and Statistical Manual for Mental Disorders (DSM)," have undisclosed financial ties to the pharmaceutical companies whose drugs are used to treat those conditions. The April 2006 study in the journal, Psycho... - Court Allows Eli Lilly to Bury Zyprexa Documents
Dec-21-06 New York, NY Alaskan attorney, Jim Gottstein, says that after being served with a mandatory injunction, he has returned the internal Eli Lilly documents that he obtained in litigation and provided to the New York Times to the court. Information from the documents related to Lilly's antipsychotic drug, Zyprexa , was highlighted two days in a row in fr... - Drug Makers Trolling for Infants and Toddlers
Dec-21-06 The motive behind Big Pharma's promotion of the off-label prescribing of psychotropic drugs is market expansion and unfortunately, it just so happens that children provide the richest harvest because most kids are covered by health insurance plans or Medicaid. The various recruitment schemes include trolling for customers among infants and toddlers betwee...